Talaris Therapeutics, Inc. (TALS) - Stock Prices, Stock Peers & Analysis

Home
TALS

Company Name	Talaris Therapeutics, Inc.
Symbol	TALS
Currency	USD
Price	2.72
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	116,444,832
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	55.58%
52-week-range	0.89 - 3.29
Industry	Biotechnology
Sector	Healthcare
CEO	Ms. Mary Kay Fenton
Website	https://talaristx.com

An error occurred while fetching data.

About Talaris Therapeutics, Inc.

Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ transplantation and severe autoimmune diseases, as well as severe non-malignant blood, immune, and